Maalox Total Relief and Maalox Liquid Products: Medication Use Errors.

Provide Feedback |

Submit a Case

Press Release/Announcement

Maalox Total Relief and Maalox Liquid Products: Medication Use Errors.

March 3, 2010

MedWatch Safety Alert. Rockville, MD: US Food and Drug Administration; February 17, 2010.

This announcement alerts consumers and health care professionals to dangers associated with name confusion on a widely used over-the-counter medicine.

Free full text

Related Resources From the Same Author(s)

Apotex Corp. issues voluntary nationwide recall of Enoxaparin Sodium Injection, USP due to mislabeling of syringe barrel measurement markings.

February 17, 2021

Codeine use in certain children after tonsillectomy and/or adenoidectomy may lead to rare, but life-threatening adverse events or death.

February 20, 2013

Hydrocodone bitartrate and acetaminophen tablets, phenobarbital tablets by Qualitest: recall—incorrect package labeling.

February 16, 2011

Important Warnings and Instructions for Heparin Sodium Injection (Baxter).

February 20, 2008

Heparin sodium injection 10,000 units/mL, and HEP-LOCK U/P 10 units/mL medication errors.

February 21, 2007

Public Health Notification from FDA: Vail Products Enclosed Bed Systems.

December 19, 2007

Nimodipine Capsules (marketed as Nimotop).

March 1, 2006

FDA alerts patients and health care professionals of EpiPen auto-injector errors related to device malfunctions and user administration.

April 8, 2020

Medication errors resulting from confusion between risperidone (Risperdal) and ropinirole (Requip).

June 22, 2011

Wear face masks with no metal during MRI exams.

December 16, 2020

Related Resources

FDA Safety Communication: update--robotically-assisted surgical devices in mastectomy.

August 20, 2021

FDA advises health care professionals and patients about insulin pen packaging and dispensing.

October 28, 2020

Fentanyl transdermal system (marketed as Duragesic) information.

July 10, 2015

FDA requires label warnings to prohibit sharing of multi-dose diabetes pen devices among patients.

March 11, 2015

Important change to heparin container labels to clearly state the total drug strength.

December 19, 2012

Medication errors resulting from confusion between risperidone (Risperdal) and ropinirole (Requip).

June 22, 2011

Serious medication errors from intravenous administration of nimodipine oral capsules.

August 11, 2010

Information for healthcare professionals: risk of transmission of blood-borne pathogens from shared use of insulin pens.

April 8, 2009

Important information for the safe use of Tussionex Pennkinetic Extended-Release Suspension.

March 26, 2008

Heparin sodium injection 10,000 units/mL, and HEP-LOCK U/P 10 units/mL medication errors.

February 21, 2007

See More About The Topic

Home Care

Health Care Providers

Patients

Pharmacy

Look-Alike, Sound-Alike Drugs

To sign up for updates or to access your subscriber preferences, please enter your email address below.

5600 Fishers Lane
Rockville, MD 20857
Telephone: (301) 427-1364

Maalox Total Relief and Maalox Liquid Products: Medication Use Errors.

Connect With Us

Sign up for Email Updates

Agency for Healthcare Research and Quality

Maalox Total Relief and Maalox Liquid Products: Medication Use Errors.

Connect With Us

Sign up for Email Updates

Agency for Healthcare Research and Quality

Submit Your Innovations

Continue as a Guest

Continue Logged In

Submit Your Innovations

Continue as a Guest

Continue logged in

New Users to the PSNet site